Join Us

Ibrance

Save as Favorite
Sign in to receive recommendations (Learn more)

Leer esta página en español

Brand name: Ibrance

Chemical name: Palbociclib

Class: Cyclin-dependent kinase (CDK) 4/6 inhibitor. Kisqali and Verzenio are other CDK4/6 inhibitors used to treat breast cancer.

How it works: A kinase is a type of protein in the body that helps control cell division. Ibrance works by inhibiting the kinase and stopping cancer cells from dividing and growing.

Uses: Ibrance is used in combination with an aromatase inhibitor to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that hasn’t been treated with hormonal therapy before in postmenopausal women and men. Arimidex (chemical name: anastrozole), Aromasin (chemical name: exemestane), and Femara (chemical name: letrozole) are aromatase inhibitors.

Ibrance also is approved to be used in combination with Faslodex (chemical name: fulvestrant) to treat advanced-stage or metastatic, hormone-receptor-positive, HER2-negative breast cancer that has grown after being treated with hormonal therapy in women and men. Premenopausal and perimenopausal women who take Ibrance in combination with Faslodex also should be treated with a medicine to suppress ovarian function.

How it’s given: Ibrance is a pill taken by mouth.

Side effects:

Read more about Ibrance.

Join the Conversation


Reference

  1. Ibrance (palbociclib) prescribing information. Pfizer. New York, NY. 2018. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=2191

Was this article helpful? Yes / No
Rn icon

Can we help guide you?

Create a profile for better recommendations



Beta How does this work? Learn more

Covid19 sidebar v04.4
Back to Top